CRISPR detection of cardiac tumor-associated microRNAs
Youlin Fu,
No information about this author
Peng Zhang,
No information about this author
Feng Chen
No information about this author
et al.
Molecular Biology Reports,
Journal Year:
2025,
Volume and Issue:
52(1)
Published: Jan. 11, 2025
Language: Английский
Boosting CRISPR/Cas12a intrinsic RNA detection capability through pseudo hybrid DNA-RNA substrate design
Yi Liu,
No information about this author
Jie Qiao,
No information about this author
Junqi Zhang
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Abstract
The
CRISPR/Cas12a
system
is
known
for
its
intrinsic
RNA-guided
trans-cleavage
activity;
however,
RNA
detection
sensitivity
limited,
with
conventional
methods
typically
achieving
limits
in
the
nanomolar
range.
Here,
we
report
development
of
"Pseudo
Hybrid
DNA-RNA"
(PHD)
assay
that
significantly
enhances
capability
Cas12a.
PHD
achieves
a
striking
limit
7.7
pM
using
single
crRNA
and
33.8
fM
pooled
crRNAs.
Importantly,
this
exhibits
ultra-high
specificity,
capable
distinguishing
mutated
target
sequences
at
PAM-distal
region.
It
can
also
detect
ultrashort
as
short
6–8
nucleotides
long
RNAs
complex
secondary
structures.
Additionally,
enables
PAM-free
attomolar-level
DNA
detection.
We
further
demonstrate
practical
utility
by
successfully
detecting
miR-155
biomarkers
HPV16
clinical
samples.
anticipate
design
principles
established
study
be
extended
to
other
CRISPR/Cas
enzymes,
thereby
accelerating
powerful
nucleic
acid
testing
tools
various
applications.
Language: Английский
BE-CATCH: Bioamplifier-Equipped CRISPR-Cas12a Transduction System Coupled with Commercial Pregnancy Test Strips to Harness Signal-on Point-of-Care Detection
Tongshan Zuo,
No information about this author
Xiang Chen,
No information about this author
Yan Yu
No information about this author
et al.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 15, 2025
Repurposing
existing
commercial
diagnostic
equipment
to
enable
portable
analysis
of
diverse
targets
is
driving
the
development
affordable
point-of-care
testing
(POCT).
Interestingly,
we
found
that
goat
antimouse
IgG
could
replace
human
chorionic
gonadotropin
(hCG)
make
T
line
pregnancy
test
strips
(PTS)
appear
red
color
and
accordingly
synthesized
a
novel
signal
output
probe,
which
eliminated
intricate
hCG
covalent
coupling
steps,
meet
multiple
needs
expanded
POCT.
Given
this,
introduced
separation-free
universal
POCT
strategy
termed
bioamplifier-equipped
CRISPR-Cas12a
transduction
system
coupled
with
PTS
harness
signal-on
detection
(BE-CATCH).
Specifically,
target
inputs
were
converted
amplified
by
multiplied
strand
displacement
amplification-based
bioamplifier,
thereby
activating
Cas12a's
trans-cleavage
activity.
Then,
activated
Cas12a
would
cleave
connector
indiscriminately,
ultimately
kept
probe
in
free
state;
thus,
be
translated
into
colorimetric
on
PTS.
This
not
only
provided
boosted
sensitivity
specificity
but
also
enhanced
user-friendliness
maintaining
mode.
We
demonstrated
versatility
BE-CATCH
through
selectively
detecting
miR-155
flap
endonuclease
1.
its
broad
adaptability,
provide
an
appealing
option
broaden
application
biomedical
diagnostics.
Language: Английский